Results 201 to 210 of about 22,304 (253)
Some of the next articles are maybe not open access.
Clinical Pharmacokinetics, 1995
Published values for the serum concentrations and pharmacokinetic parameters of levonorgestrel after administration of various doses of levonorgestrel alone or with ethinylestradiol are reviewed. Most data apply to oral administration of the gestagen, with the smaller amount of data for other modes of administration, e.g. subcutaneous, intravaginal and
openaire +3 more sources
Published values for the serum concentrations and pharmacokinetic parameters of levonorgestrel after administration of various doses of levonorgestrel alone or with ethinylestradiol are reviewed. Most data apply to oral administration of the gestagen, with the smaller amount of data for other modes of administration, e.g. subcutaneous, intravaginal and
openaire +3 more sources
Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems.
Journal of the American Medical Association (JAMA)This study uses data from nationwide Danish registries to assesses breast cancer risk with continuous use of levonorgestrel-releasing intrauterine systems, accounting for other hormonal exposures.
L. Mørch +4 more
semanticscholar +1 more source
Obstetrics and Gynecology
The venous thromboembolic risk of estradiol valerate–dienogest combined oral contraceptives is significantly decreased compared with ethinyl estradiol–levonorgestrel combined oral contraceptives.
A. Bauerfeind +3 more
semanticscholar +1 more source
The venous thromboembolic risk of estradiol valerate–dienogest combined oral contraceptives is significantly decreased compared with ethinyl estradiol–levonorgestrel combined oral contraceptives.
A. Bauerfeind +3 more
semanticscholar +1 more source
The journal of obstetrics and gynaecology research, 2020
To evaluate the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative replacement of levonorgestrel‐releasing intrauterine system (LNG‐IUS) in the treatment of symptomatic adenomyosis.
Feng Sun +5 more
semanticscholar +1 more source
To evaluate the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative replacement of levonorgestrel‐releasing intrauterine system (LNG‐IUS) in the treatment of symptomatic adenomyosis.
Feng Sun +5 more
semanticscholar +1 more source
Treatment of symptomatic adenomyosis with the levonorgestrel‐releasing intrauterine system
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019To determine the long‐term effects of using the levonorgestrel‐releasing intrauterine system (LNG‐IUS) to treat symptomatic adenomyosis.
Lei Li, J. Leng, S. Jia, J. Lang
semanticscholar +1 more source
The journal of obstetrics and gynaecology research, 2019
To evaluate the efficacy of levonorgestrel intrauterine system (LNG‐IUS) treatment in patients with previous cesarean delivery scar defect (PCDS)‐related intermenstrual bleeding.
Ying-Yi Chen +3 more
semanticscholar +1 more source
To evaluate the efficacy of levonorgestrel intrauterine system (LNG‐IUS) treatment in patients with previous cesarean delivery scar defect (PCDS)‐related intermenstrual bleeding.
Ying-Yi Chen +3 more
semanticscholar +1 more source
Degradation Kinetics and Transformation Products of Levonorgestrel and Quinestrol in Soils.
Journal of Agricultural and Food Chemistry, 2019Levonorgestrel (LNG) and quinestrol (QUN) are typical endocrine disruptors that enter the soil via sewage irrigation and sludge return. However, the fates of both compounds in soil are not well-understood.
Tao Tang +6 more
semanticscholar +1 more source
Effect of levonorgestrel emergency contraception on implantation and fertility: a review.
Contraception, 2022M. Endler +2 more
semanticscholar +1 more source